Plunkett Research Online: Invion

INVION (IVIXF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Invion Ltd is incorporated in Australia. It is a clinical-stage biotechnology company. It focuses on the treatments for inflammatory diseases. It develops products such as INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast) for asthma and smoking cessation. The company has completed the Ph.....



Invion
Ticker: IVIXF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 732950500
Fax: 61 732950599
Address: c/- Coogans Pty Ltd
Suite 4, 924 Gympie Road Chermside
Level 11
Brisbane, QLD 4000 Australia

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription

Invion Ltd is incorporated in Australia. It is a clinical-stage biotechnology company. It focuses on the treatments for inflammatory diseases. It develops products such as INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast) for asthma and smoking cessation. The company has completed the Ph.....See More See More

Auditor: Ernst & Young
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: